Thursday 24 July, 2014

Hormone linked to mortality in chronic kidney disease patients

Published On: Thu, Jun 16th, 2011 | Kidney Diseases | By BioNews

Researchers at the University of Miami have identified a new marker to predict progressive kidney failure, death.

They have found that a high level of a hormone that regulates phosphate is associated with an increased risk of kidney failure and death among chronic kidney disease (CKD) patients.

Senior study author Myles Wolf, M.D., M.M.Sc., at the University of Miami, believes this discovery could lead to earlier diagnosis and treatment of phosphate problems.

Treatment typically consists of dietary phosphate restriction and phosphate binders — medications that work like a sponge to soak up phosphate in the gut.

Our bodies need phosphorus to build and repair bones and teeth, help cells function and maintain DNA. With fine-tuned regulation from hormones like FGF23, the kidneys help control the amount of phosphate in the blood by eliminating the excess.

Elevated phosphate levels are often a consequence of advanced kidney disease or damage. But too much phosphate may also make kidney disease worse, Wolf said.
The study was recently published in the Journal of the American Medical Association.

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

More from Kidney Diseases
  • There’s No Place Like Home — for Dialysis
  • New vaccine brings hope for kidney cancer patients
  • Iced tea may cause painful kidney stones
  • Fatty liver disease poses no excess threat for mortality
  • Pakistani kid gets liver transplant in India
  • Visit us on Google+